ArticleDigestive diseases and sciences2015

Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.

Carlos Taxonera et al.PubMed ↗Publisher ↗

No numbers read from the abstract.